$SNCA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in PALISADE BIO, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in PALISADE BIO, INC.. Get notifications about new insider transactions in PALISADE BIO, INC. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 29 2021 | SNCA | PALISADE BIO, INC. | Williams Donald Allen | Director | Option Exercise | A | 26.85 | 4,406 | 118,301 | 4,406 | |
Apr 29 2021 | SNCA | PALISADE BIO, INC. | Williams Donald Allen | Director | Option Exercise | A | 41.20 | 10,203 | 420,364 | 10,203 | |
Apr 29 2021 | SNCA | PALISADE BIO, INC. | Trenschel Robert J. | Director | Option Exercise | A | 26.85 | 1,223 | 32,838 | 1,223 | |
Apr 29 2021 | SNCA | PALISADE BIO, INC. | Trenschel Robert J. | Director | Option Exercise | A | 41.20 | 13,595 | 560,114 | 13,595 | |
Apr 29 2021 | SNCA | PALISADE BIO, INC. | Trenschel Robert J. | Director | Option Exercise | A | 41.20 | 40,785 | 1,680,342 | 40,785 | |
Apr 29 2021 | SNCA | PALISADE BIO, INC. | Trenschel Robert J. | Director | Option Exercise | A | 26.85 | 4,406 | 118,301 | 4,406 | |
Apr 29 2021 | SNCA | PALISADE BIO, INC. | Trenschel Robert J. | Director | Option Exercise | A | 41.20 | 1,298 | 53,478 | 1,298 | |
Apr 29 2021 | SNCA | PALISADE BIO, INC. | Trenschel Robert J. | Director | Option Exercise | A | 41.20 | 10,182 | 419,498 | 10,182 | |
Apr 29 2021 | SNCA | PALISADE BIO, INC. | Trenschel Robert J. | Director | Grant | A | 0.00 | 304,479 | 0 | 304,479 | 0 to 304.5 K |
Apr 29 2021 | SNCA | PALISADE BIO, INC. | Neal James R | Director | Option Exercise | A | 26.85 | 4,406 | 118,301 | 4,406 | |
Apr 29 2021 | SNCA | PALISADE BIO, INC. | Neal James R | Director | Option Exercise | A | 41.20 | 1,298 | 53,478 | 1,298 | |
Apr 29 2021 | SNCA | PALISADE BIO, INC. | Neal James R | Director | Option Exercise | A | 41.20 | 5,091 | 209,749 | 5,091 | |
Apr 29 2021 | SNCA | PALISADE BIO, INC. | Neal James R | Director | Option Exercise | A | 53.33 | 1,359 | 72,475 | 1,359 | |
Apr 29 2021 | SNCA | PALISADE BIO, INC. | Neal James R | Director | Option Exercise | A | 53.33 | 3,398 | 181,215 | 3,398 | |
Apr 29 2021 | SNCA | PALISADE BIO, INC. | Neal James R | Director | Option Exercise | A | 27.59 | 849 | 23,424 | 849 | |
Apr 29 2021 | SNCA | PALISADE BIO, INC. | Hallam Thomas | Chief Executive Off ... | Option Exercise | A | 17.72 | 27,190 | 481,807 | 27,190 | |
Apr 29 2021 | SNCA | PALISADE BIO, INC. | Hallam Thomas | Chief Executive Off ... | Option Exercise | A | 26.85 | 12,294 | 330,094 | 12,294 | |
Apr 29 2021 | SNCA | PALISADE BIO, INC. | Hallam Thomas | Chief Executive Off ... | Option Exercise | A | 53.33 | 15,002 | 800,057 | 15,002 | |
Apr 29 2021 | SNCA | PALISADE BIO, INC. | Hallam Thomas | Chief Executive Off ... | Option Exercise | A | 41.20 | 20,392 | 840,150 | 20,392 | |
Apr 29 2021 | SNCA | PALISADE BIO, INC. | Hallam Thomas | Chief Executive Off ... | Option Exercise | A | 41.20 | 8,754 | 360,665 | 8,754 | |
Apr 29 2021 | SNCA | PALISADE BIO, INC. | Hallam Thomas | Chief Executive Off ... | Option Exercise | A | 41.20 | 22,730 | 936,476 | 22,730 | |
Apr 29 2021 | SNCA | PALISADE BIO, INC. | Hallam Thomas | Chief Executive Off ... | Option Exercise | A | 27.59 | 95,572 | 2,636,831 | 95,572 | |
Apr 29 2021 | SNCA | PALISADE BIO, INC. | Hallam Thomas | Chief Executive Off ... | Option Exercise | A | 27.59 | 2,719 | 75,017 | 2,719 | |
Apr 29 2021 | SNCA | PALISADE BIO, INC. | Hallam Thomas | Chief Executive Off ... | Option Exercise | A | 27.59 | 477 | 13,160 | 477 | |
Apr 29 2021 | SNCA | PALISADE BIO, INC. | Hallam Thomas | Chief Executive Off ... | Option Exercise | A | 27.59 | 6,797 | 187,529 | 6,797 | |
Apr 29 2021 | SNCA | PALISADE BIO, INC. | Hallam Thomas | Chief Executive Off ... | Option Exercise | A | 18.39 | 27,189 | 500,006 | 27,189 | |
Apr 29 2021 | SNCA | PALISADE BIO, INC. | Hallam Thomas | Chief Executive Off ... | Option Exercise | A | 14.72 | 4,078 | 60,028 | 4,078 | |
Apr 29 2021 | SNCA | PALISADE BIO, INC. | Hallam Thomas | Chief Executive Off ... | Grant | A | 0.00 | 1,592 | 0 | 1,592 | 0 to 1.6 K |
Apr 29 2021 | SNCA | PALISADE BIO, INC. | Finley John David | Chief Financial Off ... | Option Exercise | A | 41.20 | 293 | 12,072 | 293 | |
Apr 29 2021 | SNCA | PALISADE BIO, INC. | Finley John David | Chief Financial Off ... | Option Exercise | A | 41.20 | 325 | 13,390 | 325 | |
Apr 29 2021 | SNCA | PALISADE BIO, INC. | Finley John David | Chief Financial Off ... | Option Exercise | A | 27.59 | 27 | 745 | 27 | |
Apr 29 2021 | SNCA | PALISADE BIO, INC. | Finley John David | Chief Financial Off ... | Option Exercise | A | 27.59 | 516 | 14,236 | 516 | |
Apr 29 2021 | SNCA | PALISADE BIO, INC. | Finley John David | Chief Financial Off ... | Option Exercise | A | 27.59 | 40 | 1,104 | 40 | |
Apr 29 2021 | SNCA | PALISADE BIO, INC. | Finley John David | Chief Financial Off ... | Option Exercise | A | 27.59 | 503 | 13,878 | 503 | |
Apr 29 2021 | SNCA | PALISADE BIO, INC. | Finley John David | Chief Financial Off ... | Option Exercise | A | 27.59 | 339 | 9,353 | 339 | |
Apr 29 2021 | SNCA | PALISADE BIO, INC. | Finley John David | Chief Financial Off ... | Option Exercise | A | 41.20 | 49 | 2,019 | 49 | |
Apr 29 2021 | SNCA | PALISADE BIO, INC. | Finley John David | Chief Financial Off ... | Option Exercise | A | 41.20 | 51 | 2,101 | 51 | |
Apr 29 2021 | SNCA | PALISADE BIO, INC. | Finley John David | Chief Financial Off ... | Option Exercise | A | 27.59 | 95 | 2,621 | 95 | |
Apr 29 2021 | SNCA | PALISADE BIO, INC. | Finley John David | Chief Financial Off ... | Option Exercise | A | 26.85 | 2,595 | 69,676 | 2,595 | |
Apr 29 2021 | SNCA | PALISADE BIO, INC. | Finley John David | Chief Financial Off ... | Option Exercise | A | 26.85 | 7,952 | 213,511 | 7,952 | |
Apr 29 2021 | SNCA | PALISADE BIO, INC. | Finley John David | Chief Financial Off ... | Option Exercise | A | 53.33 | 9,702 | 517,408 | 9,702 | |
Apr 29 2021 | SNCA | PALISADE BIO, INC. | Finley John David | Chief Financial Off ... | Option Exercise | A | 41.20 | 19,033 | 784,160 | 19,033 | |
Apr 29 2021 | SNCA | PALISADE BIO, INC. | Finley John David | Chief Financial Off ... | Option Exercise | A | 41.20 | 5,662 | 233,274 | 5,662 | |
Apr 29 2021 | SNCA | PALISADE BIO, INC. | Finley John David | Chief Financial Off ... | Option Exercise | A | 41.20 | 14,708 | 605,970 | 14,708 | |
Apr 29 2021 | SNCA | PALISADE BIO, INC. | Finley John David | Chief Financial Off ... | Option Exercise | A | 27.59 | 52,068 | 1,436,556 | 52,068 | |
Apr 29 2021 | SNCA | PALISADE BIO, INC. | Finley John David | Chief Financial Off ... | Option Exercise | A | 27.59 | 9,516 | 262,546 | 9,516 | |
Apr 29 2021 | SNCA | PALISADE BIO, INC. | Finley John David | Chief Financial Off ... | Option Exercise | A | 27.59 | 10,418 | 287,433 | 10,418 | |
Apr 29 2021 | SNCA | PALISADE BIO, INC. | Finley John David | Chief Financial Off ... | Grant | A | 0.00 | 26,322 | 0 | 26,322 | 0 to 26.3 K |
Apr 29 2021 | SNCA | PALISADE BIO, INC. | Finley John David | Chief Financial Off ... | Grant | A | 0.00 | 2,396 | 0 | 2,396 | 0 to 2.4 K |
Apr 29 2021 | SNCA | PALISADE BIO, INC. | Diaz Stephanie | Director | Option Exercise | A | 26.85 | 4,406 | 118,301 | 4,406 | |
Apr 29 2021 | SNCA | PALISADE BIO, INC. | Diaz Stephanie | Director | Option Exercise | A | 41.20 | 10,203 | 420,364 | 10,203 | |
Apr 29 2021 | SNCA | PALISADE BIO, INC. | Dawson Michael John | Chief Medical Offic ... | Option Exercise | A | 26.85 | 2,800 | 75,180 | 2,800 | |
Apr 29 2021 | SNCA | PALISADE BIO, INC. | Dawson Michael John | Chief Medical Offic ... | Option Exercise | A | 41.20 | 1,962 | 80,834 | 1,962 | |
Apr 29 2021 | SNCA | PALISADE BIO, INC. | Dawson Michael John | Chief Medical Offic ... | Option Exercise | A | 41.20 | 5,084 | 209,461 | 5,084 | |
Apr 29 2021 | SNCA | PALISADE BIO, INC. | Dawson Michael John | Chief Medical Offic ... | Option Exercise | A | 53.33 | 20,391 | 1,087,452 | 20,391 | |
Apr 29 2021 | SNCA | PALISADE BIO, INC. | Dawson Michael John | Chief Medical Offic ... | Option Exercise | A | 27.59 | 5,438 | 150,034 | 5,438 | |
Apr 26 2021 | SNCA | Seneca Biopharma, ... | Mazzo David J | Director | Option Exercise | A | 0.00 | 6,000 | 0 | 6,000 | |
Apr 26 2021 | SNCA | Seneca Biopharma, ... | GRAY MARY ANN | Director | Option Exercise | A | 0.00 | 6,000 | 0 | 6,000 | |
Apr 26 2021 | SNCA | Seneca Biopharma, ... | Csimma Cristina | Director | Option Exercise | A | 0.00 | 6,000 | 0 | 6,000 | |
Apr 26 2021 | SNCA | Seneca Biopharma, ... | Wei Binxian | Director | Option Exercise | A | 0.00 | 6,000 | 0 | 6,000 | |
Apr 07 2020 | SNCA | Seneca Biopharma, ... | Wei Binxian | Director | Option Exercise | A | 0.00 | 6,000 | 0 | 6,000 | |
Apr 07 2020 | SNCA | Seneca Biopharma, ... | Csimma Cristina | Director | Option Exercise | A | 0.00 | 6,000 | 0 | 6,000 | |
Apr 07 2020 | SNCA | Seneca Biopharma, ... | GRAY MARY ANN | Director | Option Exercise | A | 0.00 | 6,000 | 0 | 6,000 | |
Apr 07 2020 | SNCA | Seneca Biopharma, ... | Mazzo David J | Director | Option Exercise | A | 0.00 | 6,000 | 0 | 6,000 | |
Jul 03 2019 | CUR | Neuralstem, Inc. | SMITH SANDFORD D | Director | Grant | A | 0.00 | 166,667 | 0 | 219,916 | 53.2 K to 219.9 K (+313.00 %) |
Jul 03 2019 | CUR | Neuralstem, Inc. | OLDAKER WILLIAM CLYDE | Director | Option Exercise | A | 0.30 | 187,510 | 56,272 | 187,510 | |
Jul 03 2019 | CUR | Neuralstem, Inc. | OGILVIE SCOTT VARDE | Director | Option Exercise | A | 0.30 | 187,510 | 56,272 | 187,510 | |
Jul 03 2019 | CUR | Neuralstem, Inc. | Mazzo David J | Director | Option Exercise | A | 0.30 | 187,510 | 56,272 | 187,510 | |
Jul 03 2019 | CUR | Neuralstem, Inc. | Csimma Cristina | Director | Option Exercise | A | 0.30 | 187,510 | 56,272 | 187,510 | |
Jul 05 2018 | CUR | Neuralstem, Inc. | WESTREICH STANLEY | Director | Option Exercise | A | 1.11 | 59,660 | 66,223 | 59,660 | |
Jul 05 2018 | CUR | Neuralstem, Inc. | Csimma Cristina | Director | Option Exercise | A | 1.11 | 59,660 | 66,223 | 59,660 | |
Jul 05 2018 | CUR | Neuralstem, Inc. | OGILVIE SCOTT VARDE | Director | Option Exercise | A | 1.11 | 59,660 | 66,223 | 59,660 | |
Jul 05 2018 | CUR | Neuralstem, Inc. | OLDAKER WILLIAM CLYDE | Director | Option Exercise | A | 1.11 | 59,660 | 66,223 | 59,660 | |
Jul 05 2018 | CUR | Neuralstem, Inc. | SMITH SANDFORD D | Director | Grant | A | 0.00 | 45,046 | 0 | 50,899 | 5.9 K to 50.9 K (+769.62 %) |
Nov 09 2017 | CUR | Neuralstem, Inc. | Daly Richard J | Chief Executive Off ... | Option Exercise | A | 1.12 | 100,000 | 112,000 | 100,000 | |
Jul 18 2017 | CUR | Neuralstem, Inc. | WESTREICH STANLEY | Director | Grant | A | 0.00 | 18,622 | 0 | 143,281 | 124.7 K to 143.3 K (+14.94 %) |
Jul 18 2017 | CUR | Neuralstem, Inc. | SMITH SANDFORD D | Director | Option Exercise | A | 0.00 | 9,311 | 0 | 9,311 | |
Jul 18 2017 | CUR | Neuralstem, Inc. | OLDAKER WILLIAM CLYDE | Director | Grant | A | 0.00 | 18,622 | 0 | 33,763 | 15.1 K to 33.8 K (+122.99 %) |
Jul 18 2017 | CUR | Neuralstem, Inc. | OGILVIE SCOTT VARDE | Director | Option Exercise | A | 5.37 | 13,574 | 72,892 | 13,574 | |
May 18 2017 | CUR | Neuralstem, Inc. | Daly Richard J | Chief Executive Off ... | Buy | P | 4.00 | 7,500 | 30,000 | 23,312 | 15.8 K to 23.3 K (+47.43 %) |
Apr 13 2017 | CUR | Neuralstem, Inc. | WESTREICH STANLEY | Director | Option Exercise | A | 4.96 | 33,408 | 165,704 | 33,408 | |
Mar 27 2017 | CUR | Neuralstem, Inc. | LLOYD JONES JONATHAN BRIAN | Chief Financial Off ... | Buy | P | 5.50 | 5,455 | 30,003 | 7,859 | 2.4 K to 7.9 K (+226.91 %) |
Feb 27 2017 | CUR | Neuralstem, Inc. | Daly Richard J | Chief Executive Off ... | Buy | P | 3.86 | 2,591 | 10,001 | 15,812 | 13.2 K to 15.8 K (+19.60 %) |
Jan 27 2017 | CUR | Neuralstem, Inc. | Daly Richard J | Chief Executive Off ... | Buy | P | 3.52 | 2,841 | 10,000 | 13,221 | 10.4 K to 13.2 K (+27.37 %) |
Dec 30 2016 | CUR | Neuralstem, Inc. | Daly Richard J | Chief Executive Off ... | Buy | P | 0.31 | 32,259 | 10,000 | 134,939 | 102.7 K to 134.9 K (+31.42 %) |
Nov 28 2016 | CUR | Neuralstem, Inc. | Daly Richard J | Chief Executive Off ... | Buy | P | 0.28 | 35,715 | 10,000 | 102,680 | 67 K to 102.7 K (+53.33 %) |
Oct 27 2016 | CUR | Neuralstem, Inc. | Daly Richard J | Chief Executive Off ... | Buy | P | 0.28 | 35,715 | 10,000 | 66,965 | 31.3 K to 67 K (+114.29 %) |
Sep 26 2016 | CUR | Neuralstem, Inc. | LLOYD JONES JONATHAN BRIAN | Chief Financial Off ... | Buy | P | 0.32 | 31,250 | 10,000 | 31,250 | 0 to 31.3 K |
Sep 26 2016 | CUR | Neuralstem, Inc. | Daly Richard J | Chief Executive Off ... | Buy | P | 0.32 | 31,250 | 10,000 | 31,250 | 0 to 31.3 K |
Apr 11 2016 | CUR | Neuralstem, Inc. | LLOYD JONES JONATHAN BRIAN | Chief Financial Off ... | Option Exercise | A | 0.94 | 79,776 | 74,989 | 79,776 | |
Jan 28 2016 | CUR | Neuralstem, Inc. | GARR RICHARD | CEO | Option Exercise | M | 0.00 | 19,802 | 0 | 0 | |
Jan 28 2016 | CUR | Neuralstem, Inc. | GARR RICHARD | CEO | Payment of Exercise | F | 0.67 | 6,465 | 4,332 | 1,449,804 | 1.5 M to 1.4 M (-0.44 %) |
Jan 28 2016 | CUR | Neuralstem, Inc. | GARR RICHARD | CEO | Buy | M | 0.00 | 19,802 | 0 | 1,456,269 | 1.4 M to 1.5 M (+1.38 %) |
Nov 20 2015 | CUR | Neuralstem, Inc. | OLDAKER WILLIAM CLYDE | Director | Option Exercise | M | 0.00 | 15,000 | 0 | 0 | |
Nov 20 2015 | CUR | Neuralstem, Inc. | OLDAKER WILLIAM CLYDE | Director | Buy | M | 0.00 | 15,000 | 0 | 196,826 | 181.8 K to 196.8 K (+8.25 %) |
Nov 20 2015 | CUR | Neuralstem, Inc. | GARR RICHARD | CEO | Option Exercise | M | 0.00 | 138,122 | 0 | 0 | |
Nov 20 2015 | CUR | Neuralstem, Inc. | GARR RICHARD | CEO | Payment of Exercise | F | 1.14 | 37,776 | 43,065 | 1,436,467 | 1.5 M to 1.4 M (-2.56 %) |
Nov 20 2015 | CUR | Neuralstem, Inc. | GARR RICHARD | CEO | Buy | M | 0.00 | 138,122 | 0 | 1,474,243 | 1.3 M to 1.5 M (+10.34 %) |
Nov 20 2015 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Option Exercise | M | 0.00 | 143,247 | 0 | 0 | |
Nov 20 2015 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Payment of Exercise | F | 1.14 | 39,178 | 44,663 | 930,373 | 969.6 K to 930.4 K (-4.04 %) |
Nov 20 2015 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Buy | M | 0.00 | 143,247 | 0 | 969,551 | 826.3 K to 969.6 K (+17.34 %) |
Nov 16 2015 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Sell | S | 1.09 | 25,000 | 27,250 | 826,304 | 851.3 K to 826.3 K (-2.94 %) |
Nov 09 2015 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Sell | S | 1.18 | 25,000 | 29,500 | 851,304 | 876.3 K to 851.3 K (-2.85 %) |
Nov 03 2015 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Sell | S | 1.17 | 25,000 | 29,355 | 876,304 | 901.3 K to 876.3 K (-2.77 %) |
Nov 03 2015 | CUR | Neuralstem, Inc. | GARR RICHARD | CEO | Gift | G | 0.00 | 33,476 | 0 | 1,336,121 | 1.4 M to 1.3 M (-2.44 %) |
Nov 03 2015 | CUR | Neuralstem, Inc. | GARR RICHARD | CEO | Gift | G | 0.00 | 33,477 | 0 | 1,369,597 | 1.4 M to 1.4 M (-2.39 %) |
Oct 27 2015 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Sell | S | 1.13 | 25,000 | 28,190 | 901,304 | 926.3 K to 901.3 K (-2.70 %) |
Oct 19 2015 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Sell | S | 1.23 | 25,000 | 30,690 | 926,304 | 951.3 K to 926.3 K (-2.63 %) |
Oct 13 2015 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Sell | S | 1.31 | 25,000 | 32,725 | 951,304 | 976.3 K to 951.3 K (-2.56 %) |
Oct 05 2015 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Sell | S | 1.26 | 25,000 | 31,460 | 976,304 | 1 M to 976.3 K (-2.50 %) |
Sep 28 2015 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Sell | S | 1.64 | 25,000 | 41,000 | 1,001,304 | 1 M to 1 M (-2.44 %) |
Sep 25 2015 | CUR | Neuralstem, Inc. | GARR RICHARD | CEO | Gift | G | 0.00 | 50,000 | 0 | 1,403,074 | 1.5 M to 1.4 M (-3.44 %) |
Sep 25 2015 | CUR | Neuralstem, Inc. | GARR RICHARD | CEO | Gift | G | 0.00 | 50,000 | 0 | 1,453,074 | 1.5 M to 1.5 M (-3.33 %) |
Sep 21 2015 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Sell | S | 1.52 | 25,000 | 38,078 | 1,026,304 | 1.1 M to 1 M (-2.38 %) |
Aug 18 2015 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Sell | J | 0.00 | 16,627 | 0 | 1,051,304 | 1.1 M to 1.1 M (-1.56 %) |
Jul 27 2015 | CUR | Neuralstem, Inc. | GARR RICHARD | CEO | Option Exercise | M | 0.50 | 800,000 | 400,000 | 0 | |
Jul 27 2015 | CUR | Neuralstem, Inc. | GARR RICHARD | CEO | Payment of Exercise | F | 1.93 | 380,263 | 733,908 | 1,503,074 | 1.9 M to 1.5 M (-20.19 %) |
Jul 27 2015 | CUR | Neuralstem, Inc. | GARR RICHARD | CEO | Buy | M | 0.50 | 800,000 | 400,000 | 1,883,337 | 1.1 M to 1.9 M (+73.85 %) |
Jul 24 2015 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Option Exercise | M | 0.50 | 1,200,000 | 600,000 | 0 | |
Jul 24 2015 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Payment of Exercise | F | 1.64 | 621,016 | 1,018,466 | 1,067,931 | 1.7 M to 1.1 M (-36.77 %) |
Jul 24 2015 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Buy | M | 0.50 | 1,200,000 | 600,000 | 1,688,947 | 488.9 K to 1.7 M (+245.43 %) |
Jul 06 2015 | CUR | Neuralstem, Inc. | OGILVIE SCOTT VARDE | Director | Option Exercise | A | 1.87 | 99,824 | 186,671 | 99,824 | |
Jul 06 2015 | CUR | Neuralstem, Inc. | OGILVIE SCOTT VARDE | Director | Grant | A | 0.00 | 53,476 | 0 | 86,020 | 32.5 K to 86 K (+164.32 %) |
Jul 06 2015 | CUR | Neuralstem, Inc. | WESTREICH STANLEY | Director | Grant | A | 0.00 | 106,952 | 0 | 1,564,854 | 1.5 M to 1.6 M (+7.34 %) |
Jul 06 2015 | CUR | Neuralstem, Inc. | Sohn Catherine A. | Director | Grant | A | 0.00 | 106,952 | 0 | 106,952 | 0 to 107 K |
Jul 06 2015 | CUR | Neuralstem, Inc. | SMITH SANDFORD D | Director | Grant | A | 0.00 | 106,952 | 0 | 106,952 | 0 to 107 K |
Jul 06 2015 | CUR | Neuralstem, Inc. | OLDAKER WILLIAM CLYDE | Director | Option Exercise | A | 1.87 | 99,824 | 186,671 | 99,824 | |
Jul 06 2015 | CUR | Neuralstem, Inc. | OLDAKER WILLIAM CLYDE | Director | Grant | A | 0.00 | 53,476 | 0 | 181,826 | 128.4 K to 181.8 K (+41.66 %) |
Jun 01 2015 | CUR | Neuralstem, Inc. | OLDAKER WILLIAM CLYDE | Director | Option Exercise | M | 1.32 | 60,000 | 79,200 | 0 | |
Jun 01 2015 | CUR | Neuralstem, Inc. | OLDAKER WILLIAM CLYDE | Director | Payment of Exercise | F | 1.63 | 48,589 | 79,200 | 128,350 | 176.9 K to 128.4 K (-27.46 %) |
Jun 01 2015 | CUR | Neuralstem, Inc. | OLDAKER WILLIAM CLYDE | Director | Buy | M | 1.32 | 60,000 | 79,200 | 176,939 | 116.9 K to 176.9 K (+51.31 %) |
May 29 2015 | CUR | Neuralstem, Inc. | OGILVIE SCOTT VARDE | Director | Option Exercise | M | 1.32 | 60,000 | 79,200 | 0 | |
May 29 2015 | CUR | Neuralstem, Inc. | OGILVIE SCOTT VARDE | Director | Payment of Exercise | F | 1.64 | 48,293 | 79,201 | 32,544 | 80.8 K to 32.5 K (-59.74 %) |
May 29 2015 | CUR | Neuralstem, Inc. | OGILVIE SCOTT VARDE | Director | Buy | M | 1.32 | 60,000 | 79,200 | 80,837 | 20.8 K to 80.8 K (+287.95 %) |
Apr 20 2015 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Gift | G | 0.00 | 6,800 | 0 | 488,947 | 495.7 K to 488.9 K (-1.37 %) |
Apr 02 2015 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Option Exercise | A | 3.80 | 315,126 | 1,197,479 | 315,126 | |
Apr 02 2015 | CUR | Neuralstem, Inc. | GARR RICHARD | CEO | Option Exercise | A | 3.80 | 171,008 | 649,830 | 171,008 | |
Mar 03 2015 | CUR | Neuralstem, Inc. | GARR RICHARD | CEO | Gift | G | 0.00 | 5,000 | 0 | 235,000 | 240 K to 235 K (-2.08 %) |
Dec 30 2014 | CUR | Neuralstem, Inc. | GARR RICHARD | CEO | Gift | G | 0.00 | 7,000 | 0 | 1,083,337 | 1.1 M to 1.1 M (-0.64 %) |
Dec 30 2014 | CUR | Neuralstem, Inc. | GARR RICHARD | CEO | Gift | G | 0.00 | 5,000 | 0 | 1,090,337 | 1.1 M to 1.1 M (-0.46 %) |
Dec 30 2014 | CUR | Neuralstem, Inc. | GARR RICHARD | CEO | Gift | G | 0.00 | 5,000 | 0 | 1,095,337 | 1.1 M to 1.1 M (-0.45 %) |
Sep 03 2014 | CUR | Neuralstem, Inc. | JOHE KARL | Chief Scientific Of ... | Sell | S | 4.09 | 6,000 | 24,540 | 495,747 | 501.7 K to 495.7 K (-1.20 %) |
Aug 11 2014 | CUR | Neuralstem, Inc. | WESTREICH STANLEY | Director | Option Exercise | A | 1.13 | 57,440 | 64,907 | 57,440 | |
Aug 11 2014 | CUR | Neuralstem, Inc. | OLDAKER WILLIAM CLYDE | Director | Option Exercise | A | 1.13 | 57,440 | 64,907 | 57,440 | |
Aug 08 2014 | CUR | Neuralstem, Inc. | GARR RICHARD | CEO | Gift | G | 0.00 | 68,500 | 0 | 1,100,337 | 1.2 M to 1.1 M (-5.86 %) |
Aug 08 2014 | CUR | Neuralstem, Inc. | GARR RICHARD | CEO | Gift | G | 0.00 | 68,500 | 0 | 1,168,837 | 1.2 M to 1.2 M (-5.54 %) |
Aug 07 2014 | CUR | Neuralstem, Inc. | OLDAKER WILLIAM CLYDE | Director | Option Exercise | A | 3.01 | 72,884 | 219,381 | 72,884 | |
Aug 07 2014 | CUR | Neuralstem, Inc. | OGILVIE SCOTT VARDE | Director | Option Exercise | A | 3.01 | 72,884 | 219,381 | 72,884 | |
Aug 07 2014 | CUR | Neuralstem, Inc. | WESTREICH STANLEY | Director | Option Exercise | A | 3.01 | 72,884 | 219,381 | 72,884 | |
Aug 07 2014 | CUR | Neuralstem, Inc. | Sohn Catherine A. | Director | Option Exercise | A | 3.01 | 56,892 | 171,245 | 56,892 |